Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.
about
Development of Burkholderia mallei and pseudomallei vaccinesMelioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposesStrategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.Immunogenic Burkholderia pseudomallei outer membrane proteins as potential candidate vaccine targets.Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.Present and future therapeutic strategies for melioidosis and glanders.Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.In Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosisDevelopment of vaccines against burkholderia pseudomallei.Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection.Burkholderia vaccines: are we moving forward?A case report of melioidosis in a diabetic patient in a union territory.Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge.Predictive models and correlates of protection for testing biodefence vaccines.Life sciences today and tomorrow: emerging biotechnologies.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Migration of dendritic cells facilitates systemic dissemination of Burkholderia pseudomallei.The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses.
P2860
Q26861271-E51EE1DE-CE18-4B5C-9EA1-38FA79F9371AQ27305733-1CA0F342-A318-4A2A-B54D-4B924803E39AQ28299584-23357F30-4850-4701-892C-4455E0C65F6EQ33427795-5F0A2E07-7AD1-49B5-9629-171D36810134Q33490609-DF84996F-D9BB-4E3F-9892-C616F74E1713Q33778331-1619478D-08F7-4A98-8017-22909845C357Q33797791-938876AD-A43B-4D2D-842F-557B803EBB66Q34484602-A8D01C28-4A63-4B20-8C81-8A2F8B9EED41Q35066127-D5FC4D45-0843-4158-8621-98B499ED2AE9Q35070115-C4BAFBB5-B7AB-4159-8A86-F3667ACD3509Q35234118-FFD7A5F2-50C2-44B9-AC54-CF0F770FB490Q35403794-087DE1EE-7D11-4884-A0F1-B5C6DC88BB65Q36587103-D8C246E7-E4E2-4E5B-AC3A-6A6F14FE8F53Q37156073-89AAC546-F0EC-4D2D-A5A8-B4A5F8487428Q37417238-1E8BB1A2-21B3-458C-9FF5-396E962CFB2FQ37745002-AA1AD5C5-7B6D-445E-B388-E5797A7393A6Q38845763-B72596F2-4A2A-4DA1-A226-33459C5BA04AQ38890754-8CC532F7-A006-485B-A166-DE8C0DF1DABFQ39595676-A69A465F-C18E-4276-A41C-7C3C63AE0248Q41447968-2A739DA0-B282-474B-8D61-2B13E3048AEF
P2860
Protection against heterologous Burkholderia pseudomallei strains by dendritic cell immunization.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Protection against heterologou ...... y dendritic cell immunization.
@en
Protection against heterologou ...... y dendritic cell immunization.
@nl
type
label
Protection against heterologou ...... y dendritic cell immunization.
@en
Protection against heterologou ...... y dendritic cell immunization.
@nl
prefLabel
Protection against heterologou ...... y dendritic cell immunization.
@en
Protection against heterologou ...... y dendritic cell immunization.
@nl
P2093
P2860
P1476
Protection against heterologou ...... by dendritic cell immunization
@en
P2093
Angie Westwood
E Diane Williamson
James E Eyles
Stella C Knight
Stephen J Elvin
P2860
P304
P356
10.1128/IAI.74.3.1706-1711.2006
P407
P577
2006-03-01T00:00:00Z